TAMPA, FL / ACCESSWIRE / February 21, 2023 / EV Biologics Corp (OTC PINK:YECO), today announced that it has successfully generated several mesenchymal stem/stromal cell (MSC) lines for secretome production and further cell line development. The cell banks were isolated from rigorously screened human donor tissue using xeno-free, serum-free culture media for isolation and expansion, after...Read More

TAMPA, FL / ACCESSWIRE / January 3, 2023 / EV Biologics Corp, OTC PINK:YECO, today announced that it has now closed $1,000,000 of its $2.5 million initial capitalization goal. One hundred thousand shares (100,000) have been issued at $10 per share, out of a total issuance of ten million shares to EV Biologics. Excyte, a wholly...Read More

TAMPA, FL / ACCESSWIRE / November 14, 2022 / EV Biologics Corp, (OTC PINK:YECO), today announced that it is initiating a PCAOB audit for 2021 and 2022 and intends to file an application to list on the OTCQX market during Q1, 2023. This PCAOB audit is a necessary step to finalize the previously filed corporate name...Read More

TAMPA, FL / ACCESSWIRE / August 15, 2022 / EV Biologics Corp, OTC Pink: YECO, today announced that it has launched Excyte, Inc., a wholly owned subsidiary, with $100 Million valuation. Excyte has already raised $500,000 of its $2.5 million initial capitalization goal. This funding will initially provide scale-down biomanufacturing process development and important bioanalytical data...Read More

NASHVILLE, TN / ACCESSWIRE / September 28, 2021 / EV Biologics Corp, OTC PINK:YECO, today updated shareholders with further details about its NFT and minting progress. Our NFT team has been minting the NFT, designated rEVerie, on the Ghostmarket.io platform, with an estimated completion date this week. The Company will mint 72,253 NFTs on this platform...Read More

NASHVILLE, TN / ACCESSWIRE / August 12, 2021 / EV Biologics Corp, OTC Pink:YECO, today briefed shareholders on its current value compared to other public biotechnology companies in its peer group. Please view the chart at: https://www.evbiologics.com/marketcap/. CEO Daniel Mckinney commented: ‘Our market cap is less than half that of our closest listed peer. Our goal is...Read More

NASHVILLE, TN / ACCESSWIRE / August 9, 2021 / EV Biologics Corp, OTC PINK:YECO, today updated shareholders with further details about its NFT Warrant Dividend. Attached is a preliminary image from the 3D animation still under development that will be issued as an NFT dividend Daniel Mckinney CEO said: “this NFT will capture the stunning visual...Read More

NASHVILLE, TN / ACCESSWIRE / July 26, 2021 / EV Biologics Corp, OTC PINK:YECO, today updated shareholders about its NFT dividend Warrant. The Company will distribute one (1) Warrant for every 100 shares of YECO common stock held. Each Warrant will be exercisable for one (1) NFT worth $300. Shareholders will have 90-days (October 28, 2021)...Read More

NASHVILLE, TN / ACCESSWIRE / July 22, 2021 / EV Biologics Corp., (OTC PINK:YECO) today announced that it has signed a Letter of Intent (LOI) with Lonza Cell & Gene Therapy for Process Development and Gap Analysis for biomanufacturing of a novel therapeutic composition, comprising extracellular vesicles (EVs) and particles, as well as other secreted factors...Read More

NASHVILLE, TN / ACCESSWIRE / July 19, 2021 / EV Biologics Corp, OTC PINK:YECO, today updated shareholders about its NFT dividend. On July 14, 2021 the Company announced a dividend of 1 NFT for every 100 shares of YECO common stock. The NFTs will be distributed via a special dividend to YECO’s shareholders of record on...Read More